Health Care › Services-Business Services, Nec
OPRX Stock Price Correlated With OptimizeRx Financials
External Links ⌄
Income Statement
Cash Flow
Balance Sheet
OPRX Income Statement
Enable JavaScript and reload
Revenue, Net:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
OPRX Cash Flow
Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:
OPRX Balance Sheet
Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:
Major Holders (from 13F filings)
Investment Type
Change
Value (x$1000)
increase or decrease
First Light Asset Management
1,010,931 sh
649,655 sh
180%
180%
$14,790
$8,721
Vanguard Group
868,172 sh
-138,240 sh
-14%
-14%
$12,702
-$2,214
G2 Investment Partners Management
536,409 sh
501,409 sh
1433%
1433%
$7,848
$7,260
Casdin Capital
500,000 sh
240,000 sh
92%
92%
$7,315
$2,947
Point72 Asset Management, L.P.
476,192 sh
476,192 sh
NEW
NEW
$6,967
$6,967
D. E. Shaw & Co..
471,232 sh
286,250 sh
155%
155%
$6,895
$3,787
State Street
422,902 sh
-277,997 sh
-40%
-40%
$6,187
-$5,588
Avenir
414,573 sh
-6,161 sh
-1%
-1%
$6,065
-$1,003
Federated Hermes.
355,829 sh
121,501 sh
52%
52%
$5,206
-$3,931,504
Kornitzer Capital Management /Ks
352,994 sh
53,055 sh
18%
18%
$5,164
-$5,033,811
Millennium Management
330,363 sh
275,530 sh
502%
502%
$5
$4
Geode Capital Management
323,590 sh
8,030 sh
3%
3%
$4,734
-$567
Credit Suisse Ag
320,496 sh
-11,524 sh
-3%
-3%
$4,689
-$889
JACOB ASSET MANAGEMENT OF NEW YORK
284,470 sh
10,000 sh
4%
4%
$4,162
-$449
Susquehanna International Group,
201,916 sh
-17,384 sh
-8%
-8%
$2,954
-$730
Two Sigma Advisers, Lp
191,500 sh
-5,500 sh
-3%
-3%
$2,802
-$508
Citadel Advisors
188,585 sh
175,885 sh
1385%
1385%
$2,759
$2,546
Susquehanna International Group,
Call options for 162,700 sh
162,700 sh
NEW
NEW
$2,380
$2,380
Northernrp
156,994 sh
-36,142 sh
-19%
-19%
$2,297
-$3,242,387
Citadel Advisors
Call options for 156,500 sh
156,500 sh
NEW
NEW
$2,290
$2,290
COMPANY PROFILE
NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS OptimizeRx is a digital health technology company
enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout
the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through an intelligent technology
platform embedded within a proprietary point-of-care network, OptimizeRx helps patients start and stay on their medications.
enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout
the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through an intelligent technology
platform embedded within a proprietary point-of-care network, OptimizeRx helps patients start and stay on their medications.
Free historical financial statements for OptimizeRx Corp.. See how revenue, income, cash flow, and balance sheet financials have changed over 25 quarters since 2017. Compare with OPRX stock chart to see long term trends.
Data imported from OptimizeRx Corp. SEC filings. Check original filings before making any investment decision.